Novel technologies are being sought to replace the traditional pesticides used to protect plants, particularly edible plants such as cereals. A new collaborative project between the University of Helsinki and the French National Centre for Scientific Research (CNRS) is shedding light on the efficacy of environmentally friendly RNA-based vaccines that protect plants from diseases and pests.
Plant diseases and pests cause considerable crop losses and threaten global food security. The diseases and pests have traditionally been fought with chemical pesticides, which spread throughout our environment and may be hazardous to human health, beneficial organisms and the environment.
“A new approach to plant protection involves vaccinating plants against pathogens with double-stranded RNA molecules that can be sprayed directly on the leaves,” explains Dr Minna Poranen of the Molecular and Integrative Biosciences Research Programme at the University of Helsinki’s Faculty of Biological and Environmental Sciences.
The vaccine triggers a mechanism known as RNA interference, which is an innate defence mechanism of plants, animals and other eukaryotic organisms against pathogens. The vaccine can be targeted to the chosen pathogen by using RNA molecules which share sequence identity with the pest’s genes and prevents their expression.
This means that the double-stranded RNA molecules do not affect the expression of genes in the protected plant, but only target the plant disease or pest. RNA is also a common molecule in nature that degrades rapidly rather than building up in the environment.
“The challenge in developing RNA-based vaccines to protect plants has involved the production of RNA molecules. Double-stranded RNA molecules have been produced through chemical synthesis, both as drug molecules and for research purposes, but such production methods are inefficient and expensive for plant protection,” Poranen states.
As part of the Academy of Finland’s Synthetic Biology Research Programme, Poranen’s group has developed a new production method for double-stranded RNA molecules. Together with researchers at the CNRS, the group has demonstrated the efficacy of RNA-based vaccines produced using the new method against plant virus infections. The method utilises the RNA amplification system of a bacteriophage, i.e. a bacteria-destroying virus, and the RNA production takes place in bacterial cells. This new method will enable the effective production of RNA-based vaccines and promote the development and adoption of RNA-based plant protection methods.
“It’s difficult to predict when the vaccine will be made available because no relevant legislation exists yet,” Poranen says.
The Latest on: RNA plant vaccines
via Google News
The Latest on: RNA plant vaccines
- Research efforts underway in China to hunt down novel coronaviruson January 31, 2020 at 11:27 pm
According to the CAS, Chinese researchers in virus transmission and detection, as well as drug and vaccine development, will have free access to all CSTC resources and services, such as ...
- Congressman Roe speaks about CDC vaccine plan for coronaviruson January 31, 2020 at 2:26 am
“They have taken the viral load, have done the RNA analysis in a virus, compared that to the viruses in China,” Congressman Roe said. “In 90 days, they will be in Phase 1 trials on the vaccine for ...
- GreenLight Opens New Location at Research Triangle Park in North Carolinaon January 30, 2020 at 8:03 am
As part of its continued growth, GreenLight Biosciences, Inc. has expanded to open a new location at the Alexandria Center for AgTech in Research Triangle Park (RTP), North Carolina, the largest ...
- Don’t Worry About The Coronavirus. Worry About The Flu.on January 28, 2020 at 2:17 pm
These viruses are “messy” in their reproduction, coronavirus expert Stanley Perlman of the University of Iowa told BuzzFeed News, because their genetic material is RNA. That means they lack ...
- Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronaviruson January 23, 2020 at 5:15 am
Moderna’s investigational Zika vaccine (mRNA-1893), currently in a Phase 1 study, was granted FDA Fast Track designation. Moderna has built a fully integrated, highly digitalized manufacturing plant ...
- A bone bed reveals mass death of herd of giant ground slothson January 20, 2020 at 11:04 am
The team found that, compared with younger ginkgos, older trees produced less of the plant hormone auxin, which stimulates growth ... Some mice also received a dose of claudin-coding RNA, called an ...
- New vaccines to protect infants against infectionson January 7, 2020 at 4:00 pm
found that a specialized modified-RNA (mRNA) influenza vaccine developed at Penn successfully protected young mice against the infection in the presence of maternal antibodies. The study suggests ...
- With already 2,900 people dead from the flu, we need a better vaccineon January 6, 2020 at 4:00 pm
RNA stands for ribonucleic acid, which is a long, single-stranded chain of cells that processes protein and carries genetic information of many viruses, including influenza. This discovery could help ...
- Supercharged immune cells shrink tumours with RNA vaccine’s helpon January 2, 2020 at 2:03 pm
Some mice also received a dose of claudin-coding RNA, called an RNA vaccine, that stimulates production ... But long stems often push the leaves of full-grown plants above the water’s surface.
via Bing News